Astrana Health Statistics
Total Valuation
Astrana Health has a market cap or net worth of $1.64 billion. The enterprise value is $1.77 billion.
Important Dates
The last earnings date was Thursday, November 7, 2024, after market close.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Astrana Health has 49.12 million shares outstanding. The number of shares has increased by 3.20% in one year.
| Current Share Class | 49.12M |
| Shares Outstanding | 49.12M |
| Shares Change (YoY) | +3.20% |
| Shares Change (QoQ) | +0.51% |
| Owned by Insiders (%) | 12.83% |
| Owned by Institutions (%) | 52.01% |
| Float | 35.67M |
Valuation Ratios
The trailing PE ratio is 25.71 and the forward PE ratio is 27.12. Astrana Health's PEG ratio is 1.47.
| PE Ratio | 25.71 |
| Forward PE | 27.12 |
| PS Ratio | 0.92 |
| Forward PS | 0.64 |
| PB Ratio | 2.27 |
| P/TBV Ratio | 8.86 |
| P/FCF Ratio | 23.57 |
| P/OCF Ratio | 19.98 |
| PEG Ratio | 1.47 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 16.19, with an EV/FCF ratio of 25.36.
| EV / Earnings | 28.38 |
| EV / Sales | 1.03 |
| EV / EBITDA | 16.19 |
| EV / EBIT | 20.91 |
| EV / FCF | 25.36 |
Financial Position
The company has a current ratio of 1.91, with a Debt / Equity ratio of 0.94.
| Current Ratio | 1.91 |
| Quick Ratio | 1.84 |
| Debt / Equity | 0.94 |
| Debt / EBITDA | 3.95 |
| Debt / FCF | 6.81 |
| Interest Coverage | 2.78 |
Financial Efficiency
Return on equity (ROE) is 10.26% and return on invested capital (ROIC) is 5.78%.
| Return on Equity (ROE) | 10.26% |
| Return on Assets (ROA) | 4.49% |
| Return on Capital (ROIC) | 5.78% |
| Revenue Per Employee | $956,871 |
| Profits Per Employee | $34,698 |
| Employee Count | 1,800 |
| Asset Turnover | 1.46 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Astrana Health has paid $26.02 million in taxes.
| Income Tax | 26.02M |
| Effective Tax Rate | 31.11% |
Stock Price Statistics
The stock price has decreased by -11.60% in the last 52 weeks. The beta is 1.14, so Astrana Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.14 |
| 52-Week Price Change | -11.60% |
| 50-Day Moving Average | 45.96 |
| 200-Day Moving Average | 45.36 |
| Relative Strength Index (RSI) | 18.91 |
| Average Volume (20 Days) | 303,676 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Astrana Health had revenue of $1.72 billion and earned $62.46 million in profits. Earnings per share was $1.30.
| Revenue | 1.72B |
| Gross Profit | 259.89M |
| Operating Income | 84.76M |
| Pretax Income | 96.65M |
| Net Income | 62.46M |
| EBITDA | 109.46M |
| EBIT | 84.76M |
| Earnings Per Share (EPS) | $1.30 |
Full Income StatementBalance Sheet
The company has $350.35 million in cash and $475.97 million in debt, giving a net cash position of -$125.63 million or -$2.56 per share.
| Cash & Cash Equivalents | 350.35M |
| Total Debt | 475.97M |
| Net Cash | -125.63M |
| Net Cash Per Share | -$2.56 |
| Equity (Book Value) | 507.11M |
| Book Value Per Share | 14.75 |
| Working Capital | 284.06M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $82.45 million and capital expenditures -$12.56 million, giving a free cash flow of $69.89 million.
| Operating Cash Flow | 82.45M |
| Capital Expenditures | -12.56M |
| Free Cash Flow | 69.89M |
| FCF Per Share | $1.42 |
Full Cash Flow StatementMargins
Gross margin is 15.09%, with operating and profit margins of 4.92% and 3.63%.
| Gross Margin | 15.09% |
| Operating Margin | 4.92% |
| Pretax Margin | 4.86% |
| Profit Margin | 3.63% |
| EBITDA Margin | 6.36% |
| EBIT Margin | 4.92% |
| FCF Margin | 4.06% |
Dividends & Yields
Astrana Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.20% |
| Shareholder Yield | -3.20% |
| Earnings Yield | 3.79% |
| FCF Yield | 4.24% |
Analyst Forecast
The average price target for Astrana Health is $68.20, which is 103.86% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $68.20 |
| Price Target Difference | 103.86% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Astrana Health has an Altman Z-Score of 3.61 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.61 |
| Piotroski F-Score | 5 |